Product Code: ETC4471048 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The Singapore apheresis market has experienced notable growth, driven by the increasing need for blood component separation and therapeutic procedures. Apheresis technology has become indispensable in the treatment of various medical conditions, including autoimmune disorders and organ transplantation. The market is expected to continue expanding as healthcare providers adopt apheresis techniques to provide more targeted and effective treatments, particularly for patients with complex medical needs.
The Singapore Apheresis market is driven by its applications in blood component separation, therapeutic plasma exchange, and the treatment of various medical conditions. Apheresis procedures are essential for collecting specific blood components and removing harmful substances from the bloodstream. As the demand for blood products and therapeutic treatments increases, the need for apheresis technologies and services is expected to grow, ensuring a stable blood supply and improved patient care.
The Singapore apheresis market grapples with challenges such as the need for more apheresis centers and skilled healthcare professionals. This shortage can lead to delays in patient treatment. Cost issues also come into play, as apheresis procedures can be expensive, and insurance coverage may not be comprehensive. Quality control and the need to ensure the safety of the apheresis process are continuous challenges. There is also a need for more public awareness of the benefits of apheresis, especially for rare diseases and conditions.
The Singapore apheresis market faced challenges during the COVID-19 pandemic as the healthcare system diverted resources to address the needs of COVID-19 patients. Elective apheresis procedures, including plasma and platelet donations, were affected. However, the importance of apheresis in the treatment of various medical conditions, such as autoimmune diseases and blood disorders, remained. Healthcare providers adapted by implementing safety protocols and ensuring the availability of apheresis for critical cases. The market gradually rebounded as elective procedures resumed, and the need for apheresis persisted.
In the apheresis sector, notable players include Terumo BCT, Haemonetics Corporation, and Fresenius SE & Co. KGaA. They provide apheresis equipment and services, essential for blood component separation and therapeutic procedures.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Apheresis Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Apheresis Market Revenues & Volume, 2021 & 2031F |
3.3 Singapore Apheresis Market - Industry Life Cycle |
3.4 Singapore Apheresis Market - Porter's Five Forces |
3.5 Singapore Apheresis Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Singapore Apheresis Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.7 Singapore Apheresis Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Singapore Apheresis Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.9 Singapore Apheresis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Singapore Apheresis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring apheresis treatments |
4.2.2 Technological advancements in apheresis devices and procedures |
4.2.3 Growing awareness about the benefits of apheresis therapies in Singapore's healthcare sector |
4.3 Market Restraints |
4.3.1 High costs associated with apheresis treatments |
4.3.2 Limited reimbursement policies for apheresis procedures |
4.3.3 Lack of skilled healthcare professionals proficient in apheresis techniques |
5 Singapore Apheresis Market Trends |
6 Singapore Apheresis Market, By Types |
6.1 Singapore Apheresis Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Singapore Apheresis Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Singapore Apheresis Market Revenues & Volume, By Devices, 2021-2031F |
6.1.4 Singapore Apheresis Market Revenues & Volume, By Disposable and Reagents, 2021-2031F |
6.1.5 Singapore Apheresis Market Revenues & Volume, By Software, 2021-2031F |
6.2 Singapore Apheresis Market, By Method |
6.2.1 Overview and Analysis |
6.2.2 Singapore Apheresis Market Revenues & Volume, By Centrifugation, 2021-2031F |
6.2.3 Singapore Apheresis Market Revenues & Volume, By Membrane Separation, 2021-2031F |
6.2.4 Singapore Apheresis Market Revenues & Volume, By Selective Adsorption, 2021-2031F |
6.3 Singapore Apheresis Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Singapore Apheresis Market Revenues & Volume, By Donor/Automated Apheresis, 2021-2031F |
6.3.3 Singapore Apheresis Market Revenues & Volume, By Therapeutic Apheresis, 2021-2031F |
6.4 Singapore Apheresis Market, By Component |
6.4.1 Overview and Analysis |
6.4.2 Singapore Apheresis Market Revenues & Volume, By Plasma (Plasmapheresis), 2021-2031F |
6.4.3 Singapore Apheresis Market Revenues & Volume, By Platelets (Plateletpheresis), 2021-2031F |
6.4.4 Singapore Apheresis Market Revenues & Volume, By Leukocytes (Leukapheresis or leukopheresis), 2021-2031F |
6.4.5 Singapore Apheresis Market Revenues & Volume, By Lymphocytes (Lymphopheresis or lymphapheresis), 2021-2031F |
6.4.6 Singapore Apheresis Market Revenues & Volume, By RBC's (Erythropheresis), 2021-2031F |
6.5 Singapore Apheresis Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Singapore Apheresis Market Revenues & Volume, By Blood Centers, 2021-2031F |
6.5.3 Singapore Apheresis Market Revenues & Volume, By Hospitals, 2021-2031F |
6.5.4 Singapore Apheresis Market Revenues & Volume, By Other End Users, 2021-2031F |
7 Singapore Apheresis Market Import-Export Trade Statistics |
7.1 Singapore Apheresis Market Export to Major Countries |
7.2 Singapore Apheresis Market Imports from Major Countries |
8 Singapore Apheresis Market Key Performance Indicators |
8.1 Average waiting time for apheresis procedures |
8.2 Number of apheresis procedures performed per month |
8.3 Patient satisfaction with apheresis services |
8.4 Percentage of healthcare facilities offering apheresis treatments |
8.5 Adoption rate of new apheresis technologies in Singapore |
9 Singapore Apheresis Market - Opportunity Assessment |
9.1 Singapore Apheresis Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Singapore Apheresis Market Opportunity Assessment, By Method, 2021 & 2031F |
9.3 Singapore Apheresis Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Singapore Apheresis Market Opportunity Assessment, By Component, 2021 & 2031F |
9.5 Singapore Apheresis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Singapore Apheresis Market - Competitive Landscape |
10.1 Singapore Apheresis Market Revenue Share, By Companies, 2024 |
10.2 Singapore Apheresis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |